Agilent appoints AstraZeneca CEO Pascal Soriot and Judy Brown to board; Kunz retires.

AGILENT TECHNOLOGIES, INC.

Pascal Soriot (AstraZeneca CEO) and Judy Gawlik Brown (Downtown Advisory) appointed effective May 21, 2025.
Heidi Kunz retired from the board after more than 20 years, effective same date.
Board size increased from 10 to 12 members to accommodate the new appointments.
Bylaw amended to eliminate 80% supermajority vote requirement for certain actions.

item 5.02item 5.03item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Pascal Soriot

Director

A · AGILENT TECHNOLOGIES, INC.

Effective: 2025-05-20
Filed: May 21, 2025 23:59 UTC

Mr. Soriot was appointed to serve in the class of directors that will stand for re-election at the 2028 Annual Meeting of Stockholders.

Appointed

Judy Gawlik Brown

Director

A · AGILENT TECHNOLOGIES, INC.

Effective: 2025-05-20
Filed: May 21, 2025 23:59 UTC

Ms. Brown was appointed to serve in the class of directors that will stand for re-election at the 2026 Annual Meeting of Stockholders.

Source: SEC EDGAR

accession 0000950170-25-075587

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.